Based on good progress in strategic focus areas, Chr. Hansen raises ambitions to 9-11% organic growth next year

​Through the acquisition of the assets of Austrian-based ingredient supplier Österreichische Laberzeugung Hundsbichler GmbH, Chr. Hansen will further expand its enzyme production and presence into the traditional segments of specialty cheeses.

With this expansion and modernization Chr. Hansen will be able to stay ahead of consumers’ increasing demands for natural, yet innovative food and beverage products.

CEO Mauricio Graber: “We are pleased to report that we maintained the sales momentum in Q3"

New starter culture secures mild and creamy soft cheesesChr. Hansen’s latest launch helps cheesemakers to produce soft cheese that maintains the desired taste and texture.

Chr. Hansen and FMC Corporation have announced a five-year extension of their collaboration to develop and commercialize natural solutions for the agricultural industry

​Chr. Hansen’s latest launch secures rich flavor, more flexibility and consistent quality for the cheesemaker

Clinical trial demonstrates that probiotic strain strengthens the defense against gut damage caused by regular use of household painkiller

​Chr. Hansen Holding A/S has entered into an agreement with Klaus Bjerrum to take up the position of Executive Vice President of Natural Colors Division

Prota Therapeutics, the developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen. The partnership will assess the world’s best documented probiotic strain, LGG®, in a Phase III clinical trial to develop a treatment for peanut allergy.